Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc. | CMO and Head of R&D | Common Stock | 531K | $865K | $1.63 | Jul 6, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TSHA | Taysha Gene Therapies, Inc. | Jul 5, 2022 | 2 | -$47.6K | 4 | Jul 7, 2022 | CMO and Head of R&D |
TSHA | Taysha Gene Therapies, Inc. | Jun 29, 2022 | 3 | -$183K | 4 | Jul 1, 2022 | CMO and Head of R&D |
TSHA | Taysha Gene Therapies, Inc. | Apr 6, 2022 | 1 | $0 | 4 | Apr 8, 2022 | CMO and Head of R&D |
TSHA | Taysha Gene Therapies, Inc. | Feb 23, 2022 | 1 | $0 | 4 | Feb 25, 2022 | CMO and Head of R&D |
TSHA | Taysha Gene Therapies, Inc. | Jun 29, 2021 | 7 | -$1.79M | 4 | Jul 1, 2021 | CMO and Head of R&D |